Monthly Archives: February 2020
VUMC-led study set to explore risk factors for depression recurrence
Almost 60% of older adults who have successfully been treated for depression experience a recurrence within four to five years, but little is known about why this happens or who may be at highest risk. Continue reading
Vanderbilt Wilson County Hospital receives reaccreditation from Joint Commission
The Joint Commission is an independent, not-for-profit organization that accredits and certifies more than 22,000 health care organizations and programs in the United States. Continue reading
AlertVU test scheduled for today at 1:30 p.m.
All Vanderbilt University and Medical Center students, faculty and staff are automatically enrolled in the system using their University and Medical Center email addresses. Continue reading
VUMC to break ground on Hendersonville multi-specialty clinic
Vanderbilt University Medical Center will break ground on Wednesday, March 4, at 2 p.m., on a new 31,000-square-foot facility that will offer adult outpatient specialty care, along with limited pediatric specialty care and imaging services to the citiz… Continue reading
Save the date: VU-VUMC Neuroimaging Symposium set for May 22
Towards genetic prediction of non-alcoholic fatty liver disease trajectories: PNPLA3 and beyond
Non-alcoholic fatty liver disease (NAFLD) is on the verge of becoming the leading cause of liver disease. NAFLD develops at the interface between environmental factors and inherited predisposition. Genome-wide association studies, followed by exome-wid… Continue reading
The cell circuitry of ulcerative colitis, a new view for a highly complex disease.
Metabolic inflammation – a role for hepatic inflammatory pathways as driver of comorbidities in non-alcoholic fatty liver disease (NAFLD)?
Non-alcoholic fatty liver disease (NAFLD) is a global and growing health concern. Emerging evidence points towards metabolic inflammation as a key process in the fatty liver that contributes to multiorgan morbidity. Key extrahepatic comorbidities that … Continue reading
Predicting response to rifaximin in irritable bowel syndrome with diarrhea: Is the answer blowing in the wind?
Irritable bowel syndrome (IBS) is one of the most common functional bowel disorder worldwide (Clin Gastroenterol Hepatol 2012;10:712-721). The diagnosis is based on a patient reporting a specific combination of symptoms, as defined by the Rome criteria… Continue reading